Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

NCT05854641 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia
Peripheral Arterial Disease

Interventions

BIOLOGICAL: Stempeucel®

Sponsor

Cell Biopeutics Resources Sdn Bhd

Collaborators

[object Object]
[object Object]